Consolidated Statement Of Cash Flows

ReproCELL Incorporated - Filing #7298954

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-195,013,000 JPY
-168,582,000 JPY
Interest and dividends received
31,160,000 JPY
23,921,000 JPY
Income taxes paid
-1,913,000 JPY
-1,880,000 JPY
Net cash provided by (used in) operating activities
-131,156,000 JPY
58,231,000 JPY
Cash flows from investing activities
Purchase of securities
JPY
-1,500,000,000 JPY
Purchase of property, plant and equipment
-11,995,000 JPY
-31,740,000 JPY
Purchase of investment securities
-2,000,450,000 JPY
-1,509,193,000 JPY
Net cash provided by (used in) investing activities
-412,042,000 JPY
46,220,000 JPY
Other, net
JPY
-1,352,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
680,711,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-30,320,000 JPY
66,358,000 JPY
Net increase (decrease) in cash and cash equivalents
107,191,000 JPY
170,810,000 JPY
Cash and cash equivalents
3,046,249,000 JPY
2,939,057,000 JPY
2,085,379,000 JPY
1,914,569,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.